CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis.

Source:http://linkedlifedata.com/resource/pubmed/id/20359956

Download in:

View as

General Info

PMID
20359956